TABLE 3

Percentage of dose accounted for by raltegravir and its glucuronide metabolite (M2) in urine


Subjecta

Contribution (Percentage of Dose)
M2
Raltegravir
2 16.7 3.2
3 20.8 13.3
4 20.1 6.4
5 15.8 5.0
6 26.4 16.2
7 29.9 10.5
8 30.8 6.8
Mean 22.9 8.8
S.D.
6.1
4.7
  • a The data from subject 1 were not included since this individual's fecal recovery data were considered as an outlier and not included in summary data.